LinkedIn Profile

Access Agios Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:agio 994795 Apr 21st, 2024 12:00AM Agios Pharmaceuticals 74K 507.00 Open Apr 20th, 2024 10:47PM Apr 20th, 2024 10:47PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 20th, 2024 12:00AM Agios Pharmaceuticals 74K 507.00 Open Apr 19th, 2024 10:37PM Apr 20th, 2024 04:30PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 19th, 2024 12:00AM Agios Pharmaceuticals 74K 507.00 Open Apr 18th, 2024 10:45PM Apr 18th, 2024 10:45PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 18th, 2024 12:00AM Agios Pharmaceuticals 74K 507.00 Open Apr 17th, 2024 10:45PM Apr 18th, 2024 05:50PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 17th, 2024 12:00AM Agios Pharmaceuticals 74K 506.00 Open Apr 16th, 2024 10:35PM Apr 17th, 2024 02:13PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 16th, 2024 12:00AM Agios Pharmaceuticals 74K 506.00 Open Apr 15th, 2024 10:34PM Apr 16th, 2024 10:29AM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 15th, 2024 12:00AM Agios Pharmaceuticals 74K 506.00 Open Apr 14th, 2024 10:37PM Apr 15th, 2024 04:10PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 14th, 2024 12:00AM Agios Pharmaceuticals 74K 505.00 Open Apr 13th, 2024 10:31PM Apr 13th, 2024 10:31PM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 13th, 2024 12:00AM Agios Pharmaceuticals 74K 505.00 Open Apr 12th, 2024 10:21PM Apr 13th, 2024 10:58AM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:agio 994795 Apr 12th, 2024 12:00AM Agios Pharmaceuticals 74K 506.00 Open Apr 11th, 2024 10:25PM Apr 12th, 2024 07:53AM Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. We’re a company that cares about our work, each other, and the people who are counting on us the most. We’re inspired to think big and welcome the different perspectives and backgrounds needed to deliver extraordinary results. Open Biopharmaceuticals, Rare Genetic Diseases, Cellular Metabolism, and Hemolytic Anemias Open 88 Sidney Street Cambridge MA US 02139 Agios Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.